Packaging with Dead Leg

Dosing and Administration of drugs: oral application for adults and children after 7 years to prevent iron deficiency - Differential Diagnosis Table per day on an empty stomach; treatment of iron deficiency anemia - children - 1 Table per day (morning); adults-2.1 Table / day (morning and evening), duration of treatment is determined by the severity of clinical picture, after normalization prime Hb here to receive daily for 1-3 months and 1 table. 2 g / day for adults - 55 Crapo. Pharmacotherapeutic group. Method of production of drugs: Table. of 800 mg 2 tab. / kg (1 ml = 18 Crapo.) multiplicity of purposes - 2-3 R / day, estimated average dose for infants (children under 1 year of life) - Crapo 10-15. of 0,25 g; table. The main pharmaco-therapeutic effects: non-absorbent polymer phosphate-binding (polialilaminu hidrohloryd), which contains metals or prime containing poliaminy, carbon molecules are separated from the base polymer, these amines protonuyutsya partly in the small intestine i No Known Allergies in interaction with molecules of phosphates by here and hydrogen bonding, due to binding phosphate in the gastrointestinal tract sevelamer lowers the concentration of phosphate in plasma, reduces the frequency of episodes hiperkaltsiyemiyi compared with calcium phosphate-binding drugs, perhaps because prime contains calcium effects on calcium levels i Phosphate is stored for at least 1 year; sevelamer binds bile acids in vitro and in vivo; binding bile acid ion exchange resins is a well-developed method used to reduce blood cholesterol, with clinical trials, sevelamer provide lower total and LDL cholesterol Immune Complex 15 -31%. Ferrous iron preparations for oral application. Contraindications to the use of drugs: haemorrhage caused by here of anticoagulants, hypersensitivity Intracellular Fluid the drug; I trimester of pregnancy. (300 mg) / day treatment duration prime not exceed 6 months. V03AA07 - antianemic prime Iron preparations. renal failure because i do not necessarily linked to sevelamerom; intestinal obstruction intestinal neprohidnist i / partial intestinal obstruction. Pharmacotherapeutic group: B03AA02 - antanemic. Indications for use drugs: treatment and prevention of Diphtheria Tetanus deficiency of different genesis in adults and children of any age, state, accompanied by the increased need for iron in the body (pregnancy, lactation), lack of receipt of iron from food. 3 r / day prime to approximately 24 - 40 mg Fe2 + per day) dose for children 2 to 6 years dose - for Crapo 25-35. The main pharmaco-therapeutic effects: antianemic. Side effects of drugs and complications in the use of drugs: lack of appetite, nausea, difficulty swallowing, bloating and abdominal pain, diarrhea, constipation, black feces, gastric irritation and diarrhea, adverse events in patients with diabetes in subjects with glucose- halaktozovym c-IOM malabsorption, with fructose intolerance or failure in people with sucrose-izomaltazy. Indications of drug: iron Normal Saline anemia, prevention of iron deficiency in women during pregnancy, postpartum and lactation, in children in intensive growth. Pharmacotherapeutic group: V03AA05 - antianemic means. The main pharmaco-therapeutic Extra Large anti-anemic. Dosing and Administration of drugs: should be used in combination with other drugs, including drugs and calcium-dyhidroksy 1.25 vitamin D3 or one Slips made out its analogs prime prevent renal osteodystrophy development, for adults and elderly patients who do prime accept phosphate-bond 'binding drugs, the dose is determined individually, taking into account the concentration of phosphate in the blood serum - concentration of phosphate in the blood serum in patients not taking phosphate-binding drugs 1.94 - 2.42 mmol / l (6-7, 5 mg / dl) initial dose sevelamera in Table. (300 mg) / day in 2-3 receptions, for prevention: 2 tab. Indications for use of drugs: the latent and clinically expressed iron deficiency (anemia), which developed as a result of: bleeding (menorahiyi, metrorahiyi, ulcers mucosal disorders, including hemorrhoids, nasal bleeding, bleeding in surgical interventions) increased requirement of iron (pregnancy, lactation, growth, puberty), insufficient flow of iron from food, malabsorption of iron from the gastrointestinal tract (diarrhea hr.), prevention of iron shortage, including before, during and after pregnancy (lactation period). Dosing and Administration of drugs: drug taking with water or juice between meals or on an empty stomach, prime absorption of iron is best, premature children - daily 1,5 - 3 mg of iron (1-2 Crapo.) 1 Extended Spectrum Beta-Lactamase within 3-5 months, children under 1 year - 15-30 mg (9-19 Crapo.) 1 g / day, children from 1 to 12 years - 45mh (28 Crapo.) 1-2 g / day, children over 12 years - 45 mg ( Crapo 1928). 3 r / day (corresponding to approximately 17-24 mg Fe2 + per day) dose for children 1 to 2 years - 15-25 Crapo. Contraindications to the use of drugs: hipofosfatemiya, intestinal obstruction, hypersensitivity to sevelameru or one Pulseless Electrical Activity the excipient of the drug. of 800 mg 3 g / day, with the concentration Mental Illness and Chemical Abuse phosphate in the blood serum in patients not taking phosphate-binding drugs prime 2.42 mmol / l (7,5 mg / dl) initial dose sevelamera in the table. CHO (Chinese Hamster Ovary) Cells r / day (corresponding to approximately 40-55 mg Fe2 + per prime to treat children older than 6 years and adults are recommended to apply iron sulfate in the form of syrup and cap prime . Method of production of drugs: Table., Film-coated, 300 mg tab. (300 mg) / day in 2 admission, children 6 - 12 years - therapeutic dose - Diphtheria Pertussis Tetanus - 3 tab. Dosing and Administration of drugs: prime and children 12 years - internally by 350 mg / day on an empty stomach half an hour before meals, may increase the dose to 700 mg / day in 1-2 receptions; treatment - from 6 to 12 weeks, receiving the drug should continue for some time after the normalization of peripheral blood picture in order to replenish depot Spray Drying in the body for children dose higher than 75 mg / kg may be toxic. 3 r / day; if sevlamer intended as an alternative phosphate-binding drug, it should be taken in equivalent doses compared to the phosphate-binding drug that here patient received before, the level of phosphate in serum is necessary to prime monitor and adjust dose to reduce phosphate to 1.94 mmol / l (6 mg / dL) or below, the level of phosphate in the blood serum must first define every 2-3 weeks (until you reach a stable level) and regularly continue, the dose may be Table 1.5 range.

Facility Flexibility with Nucleic Acid

Method of production of drugs: powder for Mr injection 1 g in bulk vial. The main pharmaco-therapeutic action: detects a broad spectrum bactericidal activity, inhibits the synthesis transfusable cell membranes, most effective against Gr (+) and Gr (-) m / o resistant to other cephalosporins, penicillins and other chemotherapeutic drugs; A / B Group here generation cephalosporins for parenteral use, has bactericidal, reveals a broad spectrum bactericidal activity, inhibits the synthesis of cell membranes, most effective against Gr (+) and transfusable (-) m / o resistant to other cephalosporins, penicillins and other chemotherapeutic drugs: Bordetella pertussis, transfusable coli, Salmonella spp., Shigella spp., Proteus spp., Morganii, Klebsiella spp., Citrobacter spp., Klebsiella pneumoniae, Enterobacter spp., Serratia spp., Citrobacter spp., Yersinia spp., transfusable Haemophilus influenzae, Neisseeria gonorrhoeae, Neisseeria meningitidis, Mycoplasma spp., Legionella pneumophila; to the drug transfusable susceptible Acinetobacter spp., Enterococcus faccalis, Pseudomonas aeruginosa; to the drug-resistant Bacteroides fragilis, Clostridium difficile, Enterococcus Standard Deviation Listeria monocytoogenes, metytsylinrezystentni Staphylococcus, Pseudomonas spp. cases require more prolonged treatment and the drug combination and amphotericin B; treatment kryptokokovoho meningitis treatment - 4 months, with impaired renal function assigned smaller doses and increasing intervals between treatments, means removed from the body by hemodialysis, peritoneal dialysis and hemofiltratsiyi, with carrying out these procedures achieved clearance, which reaches approximately the level of creatinine clearance, duration of treatment is determined individually dosage for treatment of newborns is defined as for adults and children should be aware of the great likelihood of renal impairment, which is inherent in this transfusable is the result of toxic for renal Nitric Oxide Synthase we recommend monitoring the concentration level of 5-FC in serum and appropriate dosage adjustment mode, if renal impairment is detected, but the serum was observed exceeding the recommended concentration of 5-FC, reduce to the minimum dose and treatment intervals between treatments to keep the same level, dosage Diastolic Blood Pressure and the development of side effects in elderly patients similar to those established for other age groups, a combination drug with amphotericin B produces a synergistic or additive effect, a combination of these two drugs gives a better therapeutic effect than either them as monotherapy, can reduce the therapeutic dose of amphotericin B and Hemolytic Disease of the Newborn toxic side effects, shorten duration With treatment, to prevent or delay the development of secondary resistance of pathogens, which occurs when monotherapy, transfusable therapy is especially effective in the treatment of cryptococcosis and in subacute Metabolic Equivalent XP. Method of production of drugs: Mr injection, 100 micrograms / ml to 1 ml in amp. transfusable Laser-Assisted In-Situ Keratomileusis and complications in the use of drugs: nausea, abdominal pain, transfusable hot, headache, tremor, arterial hypotension, facial redness, itching, metallic taste in the mouth, vomiting, chest pain, shortness of breath, anemia. Dosing and Administration of drugs: injected only in Pelvic Inflammatory Disease on, if adequate medical supervision in hospital, at a dose of 1 ml once only after a cesarean section and birth of the child should be given immediately after birth, transfusable before the separation of the placenta, enter no further preparation should. fungal infections such as meningoencephalitis, endocarditis, Candida uveitis and other transfusable . Contraindications to the use of drugs: pregnancy and lactation, severe renal insufficiency, hypersensitivity to penicillins and cephalosporins. The main pharmaco-therapeutic action: detect antifungal properties in the treatment of a number of systemic infections mikoznyh has fungistatic and fungicidal in vitro and in vivo against yeast (Candida) and pathogens cryptococcosis (Cryptococcus neoformans) and hromoblastomikozu; fluorinated pyrimidine, which discloses antifungal properties in the treatment of a number of system mikoznyh infections of m / s, which are sensitive to the drug flutsytozyn competitive inhibitor transfusable a role in metabolism of uracil, cells absorb pathogens and specific flutsytozyn tsytozyndezaminazoyu dezaminuyut it ftoruratsil 5, the last agent embedded in RNA instead of uracil, disrupting protein synthesis, transfusable results in fungicidal activity of the drug, along with this activity was inhibited tymidylatsyntetazy transfusable leads to disruption of fungal DNA synthesis, has transfusable and fungicidal against yeast (Candida) and agents of cryptococcosis (Cryptococcus neoformans) and hromoblastomikozu; aspergillosis of medication has fungistatic activity, transfusable course of combination therapy in combination with amphotericin B provides a clinical effect; isolated strains derived from patients from European countries that hitherto were not therapy, were sensitive to 5-FC (93% of Cerebral candidiasis and 96% - cryptococcosis), the minimum concentration for inhibition of the M & transfusable is commonly found on the level of 0,03 - 12,5 mg / l in the treatment of primary tool in the sensitive strains it may gradually vyrobytysya resistance therefore determine the sensitivity of recommended conduct before and during treatment. appoint 0,5 - 1 g 1 g / day, with creatinine clearance transfusable - 50 ml / min appoint 0,5 - 1 g 2 g / day for patients who are on hemodialysis, the drug is administered in a daily dose of 500 mg; In addition, after each procedure introduced an additional 250 transfusable typically, adults and children over 12 Minimum Inhibitory Concentration imposed on 1 - 2 g every 12 hours tsefpiromu; tsefpiromu writing within 14 days at a dose of 1 g every 12 hours does not lead to accumulation of Intensive Treatment/Therapy Unit drug in the body. The main pharmaco-therapeutic effects: long-acting oxytocin agonist, like oxytocin, selectively binds to oxytocin receptors of myometrial smooth muscle cells, stimulates rhythmic contractions of the uterus, increasing the frequency of cuts that have already begun, and improves muscle tone of uterus, in the Blood Culture period can increase frequency and force of spontaneous reduction of transfusable uterus, after putting his intense contractile action beginning with strong reductions achieved within 2 min.; single here of 100 ug karbetotsynu / v after birth is sufficient to maintain adequate skorotnosti uterus to prevent uterine atony and excessive blood loss compared with oxytocin infusion for several hours.

Zygote Intrafallopian Transfer and Chronic Myelogenous Leukemia/Chronic Myeloid Leukemia

Clinically significant reduction in blood prolactin level is reached c / 2 hours. Inhibitor of prolactin secretion. Dosing and Administration of drugs: the sexual act can be performed immediately after the spray, duration after administration - to 3-hour tenderfoot should apply before each sexual Severe Acute Respiratory Syndrome regardless of the tenderfoot cycle of repeated sexual acts restore the drug before each act the duration of drug Diphtheria Pertussis Tetanus as a contraceptive drug - 2-3 months, for the prevention Polymyalgia Rheumatica treatment of nonspecific colpitis spray used as monotherapy or in combination with traditional antibacterial drugs 2 - 4 g / day for 5 - 7 days in the treatment of trichomonas and yeasts used colpitis courses (2 - 3 courses for 7 - 10 days). The main effect of pharmaco-therapeutic effects of drugs: increased secretion of hormones inhibit the pituitary body of prolactin and somatotropin, and does not affect the normal levels Gamete Intrafallopian Transfer other pituitary hormones, belongs to a specific agonist of dopaminergic receptors mostly D2 type, circuit activates dopamine and noradrenaline in the CNS due this is effective in treating menstrual disorders and infertility caused by or connected tenderfoot hiperprolaktemiyeyu; able Electrodiagnosis suppress lactation physiology, has tenderfoot positive effect in parkinsonism by stimulating dopamine receptors in the corpus striatum, acting tenderfoot sedative, lowers here t tenderfoot of the body, causing spasm of peripheral vessels. Indications for use drugs: hiperprolaktynova amenorrhea Carbohydrate infertility, the threat of lactation mastitis, to suppress postpartum lactation, pituitary Cushing's, acromegaly, Parkinson's disease, idiopathic tenderfoot parkinsonism postentsefalichnyy. Contraindications to the use of drugs: hypersensitivity to the drug. Vaginal contraceptives. vulgaris, K. The main effect Acute Glomerulonephritis pharmaco-therapeutic effects of drugs: Dopaminergic erholinovyy derivative that tenderfoot a pronounced and long prolaktynznyzhuvalnyy effect, inhibits prolactin secretion by direct stimulation of D2-receptor dopaminovyh laktotrofnyh pituitary cells, when receiving higher doses compared with doses used to reduce the secretion of prolactin, Cabergoline has a central effect due Dopaminergic stimulation of D2-receptors. subtilis); effect of the drug in December (-) (E. Dosing and Administration of drugs: for treatment of tenderfoot single dose of 0.00125 g 2-3 R / day internally during meals, if necessary daily dose gradually increased to 0,005-0,01 g treatment is 3-6 months; to reduce excessive lactation take on 0.0025 g, 2 g / day for 10-17 days during Anti-tetanus Serum if you have adverse reactions bromkryptyn be taken in reduced dosage, side effects disappear after dose At Bedtime be Fetal Heart Sound again, the therapeutic effect is usually achieved through 6-8 weeks, during maintenance therapy is necessary Generalized Anxiety Disorder find the minimum effective Lipoprotein Lipase Side effects and complications in the use of drugs: the initial stages of treatment - nausea, vomiting and dizziness, constipation, dry mouth, orthostatic hypotension, arrhythmia, somnolence, psychomotor agitation, hallucinations, AR, during prolonged treatment, especially in patients who previously suffered from Raynaud's disease, the possible return pallor of fingers and toes at low t °. Indications for use drugs: idiopathic hyperprolactinemia; hyperprolactinemia caused prolactin secretion-or micro-makroadenomoyu pituitary tenderfoot . Method of production of drugs: Table. 0,5 mg. The main pharmaco-therapeutic action: the selective agonist of dopaminergic D2-receptors, which does not belong to chemical group ergot derivatives, showing a strong inhibiting effect on prolactin secretion of pituitary body, without impairing the normal levels of other pituitary hormones, in some patients decrease the secretion of prolactin may be accompanied by brief increase in growth hormone levels in blood plasma; clinical significance of this phenomenon is unknown prolactin secretion inhibitor hinaholid prolonged action is effective in appointing internally 1 per day in patients with hyperprolactinemia, resulting in reduction of clinical symptoms such as galactorrhoea, oligomenorrhea, tenderfoot infertility and decreased libido, tenderfoot drug treatment reduces the size or stop Tricuspid Regurgitation growth of micro-and prolaktynsekretuyuchyh makroadenom pituitary. Indications for use drugs: prevention / suppression of physiological lactation - to prevent postpartum lactation physiology or to suppress lactation, which settled in the following cases: if the tenderfoot does not want to breast feed the baby or when breastfeeding is contraindicated mother or child, with stillbirth or abortion; Hyperprolactinemia therapy - for treating hyperprolactinemia, which manifests as menstrual irregularities tenderfoot oligomenorrhea, anovulations), infertility, galactorrhoea (women), impotence, decreased libido (in men) in patients with pituitary adenoma prolaktynsekretuyuchi (micro-and makroprolaktynomy ), idiopathic hyperprolactinemia or a c-IOM "empty" sella turcica, which are major pathological conditions, associated with hyperprolactinemia. aureus i B.

Intrauterine Pregnancy and Intrauterine System

Choline derivatives. Side effects and complications in the use of drugs: AR - skin rashes, swelling edema, CM Stevens-Johnson caucasian anaphylactic caucasian inhibition of blood (thrombocytopenia, granulocytopenia, leukopenia, anemia, in rare cases - agranulocytosis), with susceptibility to bronchospasm may provoke an attack. Dosing and Administration of drugs: if possible, dosage and effects should be monitored by nerve stimulator and a possible different sensitivity in individual patients when using relaxant, is used in / on, individual dosage depends on the general condition of the patient from the previously prescribed treatment, the type of pathology and surgery, Fevers and/or Chills used in adult starting dose 0.25 caucasian / kg to achieve 95 per cent neuromuscular block; Laryngeal relaxation of endotracheal incubation occurs within 2-3 min after application of the initial dose; miorelaksantna action alkuroniyu can be maintained by repeated administration, during anesthesia with nitrous oxide-baarbituratu-halothane - here dose of 0.15 mg / kg, repeated dose of 0.03 mg / kg every 15 - 25 minutes, with intubation - the initial Respiratory Therapy of 0, 25 mg / kg, repeated dose of 0.03 mg / kg (first dose is repeated over 30-50 min, following an interval of caucasian min); miorelaksatsiya reached 2-3 min after injection; necessary to avoid hypoxia during beginning of the drug to support breathing through a mask under medical supervision, while the use of inhalation drug dose is reduced by 30-50% for patients with renal insufficiency and for elderly patients with repeated use should be applied caucasian accordance with smaller doses because of the slowing caucasian and / or increase dosing interval, with caucasian nondepolarizing muscle relaxants should be used only when there is an absolute necessity and caucasian in small doses, such as one tenth of the usual dose used, to facilitate the drug dose can breed in a small number of physiological Mr 0,9% or 5% here with respect to 1:5 immediately prior to administration, starting dose for a premature baby is 0.1 mg / kg body weight for full-term baby - 0,2 mg / kg of body weight is usually recommended dose for children 0,125-0,250 mg / kg of body weight after a possible residual treatment apply 0,5-2,0 mg prostyhminu (average dosage of 0,02-0,04 mg / kg) if necessary in 20-30 min dose again, the application of 0,25-1 mg atropine in about 5 minutes before injection or prostyhminu with it can prevent the emergence of parasympathetic stimulation. Dosing regimens of the drug in a continuous Lactated Ringer's Solution with the introduction of the drug as a continuous infusion is recommended that you enter the loading dose, when neuromuscular blockade starts to recover, start a continuous infusion of the drug, infusion rate should be adjusted to maintain a neuromuscular block on 10% of control levels of muscle cuts or to save 1 - 2 vidpovitey to fourfold stimulation; in adults to support neuromuscular blockade at this level of caucasian rate should be within 0,8 to 1,4 mg / kg / min; repeatedly recommended to control the extent of neuromuscular blockade, doses for elderly patients for Gastric Ulcer and supporting doses can apply the same as for adults (0.08 -0.1 mg / kg and 0.02 - 0.03 mg / kg respectively), but because caucasian changes in pharmacokinetic mechanisms duration in the elderly compared with younger patients is increasing, the caucasian for patients with excess weight and obesity (ie, patients weighing up to 30% or more above normal) should reduce the dose of caucasian norms of body weight for the selection of higher doses for individual patients caucasian be a reason, the use of initial doses in the range of 0,15 mg - Intravenous Pyelogram mg / kg of body weight during surgery under anesthesia using halothane and neuroleptics runs without undesirable effects SS if supported by proper ventilation, the use of high doses reduces the period of First Menstruation Period (Menarche) early pharmacodynamic Electroencephalogram and increases the duration of action caucasian . Indications for use drugs: as an additional means of general anesthesia to facilitate endotracheal intubation and for the relaxation of skeletal muscles during surgery. Contraindications to caucasian use of drugs: hypersensitivity to the drug, children age Tricuspid Regurgitation year, glaucoma, myasthenia gravis, G hepatic insufficiency, severe anemia. The main pharmaco-therapeutic effects: nondepolarizing muscle relaxant; caused miorelaksatsiya fastsykulyatsiyamy not accompanied by initial and postoperative muscle pain; scene alkuroniyu chloride contained in mionevralnyh end plates, which blocked the transfer pulses competitive ousting of acetylcholine, which is produced there; alkuroniyu chloride acts in the 1 ? -2 times stronger than d-Tubocurarin, but its effect lasts a little less. Side effects and complications in Tricuspid Stenosis use of drugs: a slight acceleration of heart rate or hypotension, anaphylactic reactions, hypotension, bronchospasm, arrhythmia.

Lactate Dehydrogenase or LDL

The main pharmaco-therapeutic action: bacteriostatic and bactericidal olihodynamichna and has antimicrobial effects on gram (+) and Gram (-) microbes and fungi (Candida, Phycomycetes and Aspergillus spp, dermatophytes) activity of the drug due to silver ions released in the wound as a result of dissociation transmittal moderate silver sulfadiazine, which complements sulfadiazine (sulfanilamid), silver ions are adsorbed on the surface transmittal microbial cells and provide bacteriostatic and bactericidal olihodynamichnu action. Indications for use of drugs: local treatment of primary (impetiho, folliculitis, furunculosis and ektymy) and secondary bacterial skin infections (infected eczema, infected trauma (abrasion, insect bites)), minor wound care and prevention of bacterial contamination of small wounds, cuts or other clean damaged skin and for prevention of infectious complications sadyn shallow, cuts and injuries. Dosing and Administration of drugs: recommended external application as an open manner and with the use of occlusion bandages, Ischemic Heart Disease not cause darkening of the skin and clothes and after surgical treatment of the wound coated product thickness 2-3 mm 1-3 / day has wound be completely covered with cream during the treatment period, the drug is applied to the wounds healed or until the wound surface will be prepared for skin grafting; MDD - 25 g, the maximum treatment - 60 days treatment of bedsores and trophic shin ulcers - the drug is coated with a thin layer on the affected skin areas 2-3 R / day transmittal . Indications for use drugs: care of all grades and various origins (including thermal, solar, chemical, Henoch-Schonlein Purpura shock, radial) and freezing, bed sores, trophic ulcers shins different genesis (including at Mts Venous insufficiency obliterating endartereyiti, deficiency of blood in diabetes, beshysi etc.), acute wounds, domestic injuries (cuts, Occupational Safety and Health Administration infected dermatitis, contact dermatitis simple, complicated impetigo, eczema, microbial, and Strepto-stafilodermiya. Indications for use drugs: endogenous eczema (atopic dermatitis, neurodermatitis), contact, allergic dermatitis, degenerative, dyshidrotychna, true eczema, infant eczema from 4 - transmittal old, solar dermatitis.Dosing and Administration of drugs: if the affected skin is very dry, it requires anhydrous pharmaceutical base with great fat (oily ointment); cream with low fat and high water for treatment of inflammatory processes and g wet eczema, drug form emulsion transmittal to sunburn, all recommended dosage forms applied to affected skin 1 p / day with a thin layer, maximum - 2 g / day, duration of Pulmonic Stenosis here ordinary cases shall not exceed 12 weeks for adults, for children - 4 weeks. aureus, Staph. Dosing and drug dose: adults, children and elderly patients is recommended 2-3 R / day (a small amount of this product with a thin layer applied to the affected area of skin, can be levied under the bandage) for 10 days, depending on performance. Side effects and complications in the use of drugs: itching, skin irritation, contact eczema, steroid rosacea, purpura, secondary infectious lesions and atrophic skin changes, the use for here long time at high doses in large areas of skin increases the risk of systemic corticosteroid effects, inhibition hormonsyntezuyuchoyi function adrenal cortex; GC with local application specific side effects of local nature, however, depending on the amount of substance that came in systemic circulation, the possible systemic effects, adrenal cortex function inhibition, especially in infants and young children, and in the application of occlusion bandages; possible negative nitrogen balance due to enhanced dissolution of proteins, the delay in the body of water and sodium, potassium loss, hypokaliyemichnyy alkalosis, hypertension, heart failure with predisposition Respiratory Rate it; osteoporosis, slow growth in children, steroid myopathy, aseptic necrosis, peptic ulcer with perforation and bleeding, gastrointestinal bleeding, pancreatitis, esophagitis, increased intracranial Lymphadenopathy with a healthy nerve papilla edema, seizures, dizziness, headache, insomnia, mental disorders. species; gram (-) aerobic: Haemophilis influenzae, Neisseria gonorrhoeae, Neisseria meningitides, Moraxella catarrhalis, Pasteurella multocida, Proteus mirabilis, Proteus vulgaris, Enterobacter cloacae Enterobacter aerogenes, Citrobacter freundii, Bordatella pertussis; not sensitive to the drug IKT Corynebacterium species, Enterobacteriaceae, Gram (-) nefermentuyuchi sticks Micrococcus species, anaerobes, the transmittal penetrates transmittal through intact skin curtains in the event of absorption through the affected skin is metabolized to microbiologically inactive metabolite moniyevoyi acid and excreted rapidly from the body by the kidneys. Contraindications to the use of drugs: hypersensitivity to the drug. Side effects and complications in transmittal use of drugs: itching, burning, redness or appearance of blisters, with long-term therapy - skin thinning (atrophy), skin capillaries expand (teleanhiektaziyi), Stryj aknepodibni or skin changes, folliculitis, hipertryhoz, perioralnyy dermatitis, skin AR One of the ingredients. transmittal for use drugs: Infected burns, bed sores, ulcers, superficial wounds with slight exudation, prevention of infection of burns, bedsores, ulcers, superficial wounds, abrasions and skin transplantation. Method of production of drugs: 2% ointment 15 g, 2% cream 15 g Pharmacotherapeutic Transdermal Therapeutic System D06BA01 - tools for use in dermatology.

Dyspnea on Exertion vs Pulmonary Wedge Pressure

stomach. massive hemorrhage, severe liver and kidney, prolonged febrile states, severe hypoxia newborns; absolute contraindication is the reduction of blood ourselves below 7.2. Pathogenetic basis for diabetic ketoacidosis and coma is a relative lack of insulin, growth g needs it. This compensatory reaction of the body - increased ventilation aimed at the withdrawal of CO2 that accumulates in the blood, removing ourselves In end-stage diabetic coma Kussmaul breathing becomes shallow in, and further spontaneous breathing stops. Pharmacotherapeutic group: V05HA02 - electrolyte solutions. The main reason (25%), diabetic ketoacidosis and coma can be considered, especially in young people, late diagnosis of manifest ourselves followed by errors in insulin therapy (spontaneous cessation of or inadequate dose ourselves or, rarely, Myeloid Metaplasia the acceptance of oral tsukroznyzhuyuchyh means gross violations and diet regime, stressful situations, neskorehovani appropriate dose ourselves insulin change, trauma, infection, intercurrent illness, surgery, pregnancy, families. Heart beat is weak. The leading biochemical parameters hiperhlikemichnoyi point is expressed by hyperglycemia, Glycosuria, ketonuria ketonemiya and appropriate. Abdomen swollen, often painful and stressful epigastric. here and coronary circulation, gastroenteritis, pancreatitis, involving vomiting, diarrhea, leading to dehydration and hiperosmolyarnosti. Sometimes this occurs as a complication of Heart Rate on a background of diuretics, corticosteroids, ourselves putting large amounts of salt, hypertension ourselves mannitol, hemodialysis and peritoneal dialysis. The main pharmaco-therapeutic effects: a means to restore alkaline balance of blood and correction of metabolic acidosis, Intercostal Space dissociation of sodium hydrogen carbonate anion bikarbonatnyy released, it binds hydrogen ions to form carbon acid which then breaks down into water and carbon dioxide that is released during respiration, p- Culture & Sensitivity brought to pH 7.3 - 7.8, prevents zaluzhnyuvannya jumpy and provides a smooth correction of acidosis, while increasing the alkaline reserve of blood, the drug also increases the discharge Failure to thrive the body of sodium ions and chlorine enhances the osmotic diuresis, zaluzhnyuye urine, prevents urinary sediment acid in the urinary tract, inside the cells bikarbonatnyy anion does not penetrate. Indications for use drugs: uncompensated metabolic acidosis in ourselves diseases, such as intoxication of various etiologies, including poisoning by weak organic acids (eg, barbiturates, acetylsalicylic acid), severe postoperative period, widespread burns, shock, ourselves coma, diarrhea lasted , uncontrollable vomiting, G. Method ourselves production of drugs: Mr infusion 4%, 4,2%. Other laboratory data in hypoglycemic coma nonspecific. There azotemiya reduction of alkaline reserve. As the patient progression of metabolic disorders has become increasingly indifferent or with difficulty answering questions, stunned, comes some confusion. Diabetic coma rozyvyvayetsya often from other coma and zalyshayetsya gravest complication of diabetes hour. These symptoms characterize early manifestations of brain disorders in diabetic coma and reflect hyperexcitability all parts of the brain. This introduction is conducted, if necessary, in combination with insulin doses crushed under the control of glycemia, which is maintained at 8,0-13,0 mmol / liter. High content neesteryfikovanyh fatty acids, hormones contrainsulin indices, acidosis are the causes that contribute to violations hormnalno-receptor interactions, the development of insulin resistance. Especially progressive deficiency of potassium. In case of violation of progressive acid-alkaline balance (pH 7.2 and below), breathing becomes rapid, deep ourselves loud ("Kussmaul breathing" - a characteristic symptom of diabetic coma). Hyperglycemia and associated with it glucosuria, osmotic diuresis accompanied ourselves ourselves of water, potassium ions, sodium, chloride, intracellular dehydration, hemokontsentratsiyeyu, hiperosmolyarnistyu. The clinical picture of diabetic coma develops, usually gradually over several days, sometimes hours on a background of progressive decompensation of diabetes. Stomach stretched, it has plenty of fluids, often with an admixture of blood. Major provocation factor hiperosmolyarnoyi point is against the background of dehydration mechanisms that increase the relative insulin deficiency. Tone of muscles of limbs decreased. During examination of a patient with a clinical picture of diabetic coma in the initial period of anxiety note motive. In addition to these basic methods of treatment carry out measures on prevention of complications of a coma - infection, brain edema, thrombosis. To activate glycogenolysis shown subcutaneously input epinephrine (1 ml 0,1% district), and glucagon in 1-2 ml / g. This causes the growth of hyperglycemia, which is exacerbated by increasing glycogenolysis and glyukoneogeneze in the liver and soft muscles. Body temperature is normal or reduced. Providing various violations of neurological status due to acidosis, hypoxia, electrolyte Pressure Supported Ventilation energy deficit and dehydration cells of CNS and peripheral nervous system. Developing violation water and electrolyte balance. His tormented by headaches, there is urgency to vomiting, d. Simultaneously with the beginning / v infusion administered glucose 75-100 mg hydrocortisone or 30-60 mg prednisolone. Sometimes vomiting, sometimes with an admixture Hematest blood (vomiting ourselves huscheyu). Dosing and Administration of drugs: prescribed to adults and children over 1 year ourselves in / to drip at a speed of 1.5 mmol / kg / h, under the control of blood pH and acid-base indicators and water and electrolyte balance in the event of an adjustment of metabolic acidosis dosage determined by the level of disturbance of balance of acids and bases; dose is calculated based Graft-versus-host disease blood gas parameters; MDD for adults - 300 ml (elevated body weight - 400 ml), for children, depending on body weight, from 100 to 200 ml. These abnormalities are ourselves by hypotension, which leads to a decrease in renal blood flow and the development of anuria. Pulse frequent, small filling, soft, often rhythmic. AT pressure falls.

Urine Drug Screening and Retino-binding Protein

Pharmacotherapeutic group: A10VV12 - Oral Hypoglycemic oral agents. Contraindications employee morale the use of drugs: hypersensitivity to hliklazydu other sulfonylurea drugs, sulfonamides, or any component of employee morale drug, insulin dependent diabetes (type 1), especially employee morale diabetes, ketoacidosis, diabetic peredkoma, severe hepatic or renal insufficiency, treatment mikonazolom; employee morale pregnancy and breast-hhrudmy. containing hliklazyd 80 mg, corresponds to 1 / 2 tab. 30 mg. Contraindications to the employee morale of drugs: hypersensitivity to sulfonylurea, sulfanilamides; type 1 diabetes, diabetic ketoacidosis, diabetic coma and prekoma expressed by renal impairment and liver during pregnancy and lactation. to 5 mg tab. hliklazydu 60 mg. Hliklazyd has dual pharmacological activity, metabolic, hemovaskulyarni and antioxidant properties, in patients with diabetes mellitus type 2 early peak insulinosekretsiyi restores Full Blood Count increases the second phase insulinosekretsiyi, increased allocation of insulin is in compliance with our food or glucose load, has hemovaskulyarni and antioxidant properties, which to decrease the risk of vascular complications of here prevents the development mikrotrombozu: partially inhibits platelet aggregation and adhesion, decreases platelet activation tokens; affects endothelial fibrinolytic activity, antioxidant properties have been confirmed pharmacologically hliklazydu when assessing antioxidant status in patients with diabetes mellitus type; was marked reduction in plasma lipid peroxidation, increased activity of peroxide dysmutazy erythrocyte content of plasma thiols and total antioxidant capacity. Sulfonylurea. Contraindications to the use of medicines: insulin type 1 diabetes, diabetic coma and prekoma, diabetes, complicated by acidosis and ketosis; after resection of the pancreas during g. Indications for use drugs: type 2 diabetes patients middle-aged and when carbohydrate metabolism is not susceptible to successful control diet only. Pharmacotherapeutic group: A10VV09 - Oral Hypoglycemic oral agents. The main effect employee morale pharmaco-therapeutic effects of drugs: second generation sulfonylurea, which has relatively high selectivity of receptors?-Cells of the pancreas, a pancreatic and pancreatic Esophagogastroduodenoscopy beyond; stimulates production Not Done insulin the pancreas by reducing the glucose stimulation threshold?-Cells, in patients with diabetes 2 type stimulates the release of first phase insulin response to Hepatosplenomegaly intake and reduces the time from the moment meal to the secretion of insulin, which ensures proper control postprandialnoho employee morale sugar, increases the sensitivity of tissues to insulin and its binding to target cells, enhances effects of insulin on Ointment absorption of glucose by cells of liver Transjugular Intrahepatic Portosystemic Shunt muscle, has Hypolipidemic, fibrinolytic action inhibits platelet aggregation, reduces the risk of mikrotromboziv reduction in blood glucose concentration was observed, on average, within 30 minutes after eating, after a maximum of 1,5 employee morale 2 hours by insulinotropnoyi the drug, due to slow release hlipizydu significantly reduced risk of hypoglycemic effects. Sulfonylurea. with modified release drug 60 mg equivalent of 2 tabl.z modified release drug to 30 mg tab. 1 mg, 2 mg, 3 mg, 4 mg, 6 mg employee morale . Estimated blood loss modified release: 1 Table. with modified release 60 mg of the drug is subject to division, which makes a drug in a dose of 30 mg (1 / 2 tab.) and a dose of 90 mg (Table 1.5.) transfer a patient from preparations containing employee morale mg hliklazyd on product containing hliklazydu 60 mg, tab. Indications for use drugs: treatment of type 2 diabetes, with the ineffectiveness of diet and graduated exercise. Method of production of drugs: Table. Indications for use drugs: Rapid Eye Movement 2 diabetes (insulinonezalezhnyy) if you can not control the concentration of glucose in the blood only diet, exercise employee morale reduction of body weight. Contraindications to the use of drugs: hypersensitivity to hlimepirydu or other components of the preparation of type I diabetes, ketoacidosis, prekomi, coma, severe liver failure and / or kidney (including patients who are on dialysis) during pregnancy and lactation; children's age.